ID: ALA188542

Max Phase: Preclinical

Molecular Formula: C25H21N3O7S

Molecular Weight: 507.52

Molecule Type: Small molecule

Representations

Canonical SMILES:  NC(=O)C[C@H](NS(=O)(=O)c1ccc(-c2ccc(NC(=O)c3cc4ccccc4o3)cc2)cc1)C(=O)O

Standard InChI:  InChI=1S/C25H21N3O7S/c26-23(29)14-20(25(31)32)28-36(33,34)19-11-7-16(8-12-19)15-5-9-18(10-6-15)27-24(30)22-13-17-3-1-2-4-21(17)35-22/h1-13,20,28H,14H2,(H2,26,29)(H,27,30)(H,31,32)/t20-/m0/s1

Standard InChI Key:  KJURPZKHCXAZLJ-FQEVSTJZSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 507.52

Molecular Weight (Monoisotopic): 507.1100

AlogP: 2.96

#Rotatable Bonds: 9

Polar Surface Area: 168.80

Molecular Species: ACID

HBA: 6

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.12

CX Basic pKa:

CX LogP: 2.22

CX LogD: -1.24

Aromatic Rings: 4

Heavy Atoms: 36

QED Weighted: 0.27

Np Likeness Score: -0.96

References

1. Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE..  (2005)  Identification of potent and selective MMP-13 inhibitors.,  15  (18): [PMID:16005220] [10.1016/j.bmcl.2005.06.019]

Source

Source(1):

• Scientific Literature